Mark A. Oswald, Executive Vice President and Chief Financial Officer of Adient plc, has reported a transaction involving the sale of 356 ordinary shares. This transaction occurred on November 16, 2026, and was disclosed in a recent SEC filing. Such transactions are crucial as they provide insights into the financial activities of key executives within the company.
Adient plc, incorporated in Dublin, operates in the manufacturing sector, specifically focusing on the production of motor vehicle parts and accessories. The company is identified under the SEC with the Central Index Key (CIK) number 0001670541. Its stock is traded under the symbol ADNT.
The filing reveals that Oswald disposed of 356 shares at a price of $15.15 each. Following this transaction, he retains ownership of 114,307.98 shares. The filing states, "Withholding of shares to cover taxes due in connection with the vesting of restricted stock units or performance share units, as applicable." This indicates that the transaction was part of a broader compensation strategy involving stock units.
Additionally, Oswald holds shares indirectly through a trust and a 401(k) savings plan, which further emphasizes his vested interest in the company’s performance. The filing notes that he owns 2,541 shares held by a trust and 2,768.34 shares represented by units in the company’s savings plan.
This transaction may affect perceptions of corporate governance and transparency within the motor vehicle parts and accessories sector. Stakeholders often scrutinize such transactions to gauge the confidence and financial health of executives within their companies.
The filing does not specify what actions may follow this report, leaving stakeholders to await further disclosures from the company.
Read Next
Corporación América Airports releases Q3 financial results
ITG, Inc. Director Acquires 3,500 Shares of Stock
Century Therapeutics CEO Reports Sale of 31,172 Shares
Axon Enterprise CFO Jennifer H. Mak Disposes of Shares
Rothblatt Reports Major Stock Transactions at United Therapeutics
Gogi Aalia Nighat acquires restricted stock units in Coty




